by Joel Harrison
19. December 2011 07:51
The American Food and Drug Administration may issue a public warning regarding the use of CooperVision’s Avaira Toric contact lenses after the date of a voluntary recall. This is because the company’s notification was not as broad as the FDA had suggested.
Coopervision informed of the fact of the recall and made it possible for customers to check if their lenses belonged to the recalled lots, but failed to provide information about the retailers that sold these lots. The retailers also started to notify customers of the recall, but there was a delay, which resulted in a certain number of eye injuries that could have been prevented.
According to NBC, a dozen Avaira Toric wearers have reported serious complications associated with continued use of the affected lenses. Consequently, an FDA spokesman stated that unless the company issues an appropriate warning, the FDA will do it independently.
Fortunately, CooperVision’s announcements in other countries, including the UK, were broader based and no serious problems connected with the lenses have been found since the beginning of the recall.
Subscribe